Schonfeld Strategic Advisors LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 62 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$68,000
+44.7%
11,300
-0.9%
0.00%
Q2 2022$47,000
-42.0%
11,400
-47.0%
0.00%
-100.0%
Q1 2022$81,000
+28.6%
21,500
+53.6%
0.00%0.0%
Q4 2021$63,000
-6.0%
14,000
-1.4%
0.00%0.0%
Q3 2021$67,000
-22.1%
14,200
-1.4%
0.00%0.0%
Q1 2021$86,000
+19.4%
14,400
-7.7%
0.00%0.0%
Q4 2020$72,000
-88.6%
15,600
-29.1%
0.00%
-87.5%
Q2 2020$634,00022,0000.01%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders